国药现代
(600420)
| 流通市值：116.15亿 | | | 总市值：116.15亿 |
| 流通股本：13.41亿 | | | 总股本：13.41亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 3,940,089,215.23 | 2,064,308,731.95 | 9,363,074,210.11 | 6,920,393,170.38 |
| 营业总成本 | 3,563,631,034 | 1,831,280,671.98 | 8,138,476,387.82 | 5,860,075,336.79 |
| 其他经营收益 | | | | |
| 营业利润 | 451,351,808.42 | 259,354,497.6 | 1,313,514,881.52 | 1,103,703,997.65 |
| 利润总额 | 443,096,323.13 | 248,319,195.81 | 1,327,585,038.24 | 1,115,489,059.24 |
| 净利润 | 363,224,062.4 | 192,139,353.79 | 1,142,165,623.26 | 933,228,902.01 |
| 每股收益 | | | | |
| 其他综合收益 | -49,579.45 | - | -197,049.56 | -290,964.78 |
| 综合收益总额 | 363,174,482.95 | 192,139,353.79 | 1,141,968,573.7 | 932,937,937.23 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 11,255,109,297.13 | 11,413,331,915.02 | 11,253,031,544.6 | 10,799,627,521.67 |
| 非流动资产: | | | | |
| 非流动资产合计 | 8,115,536,704.3 | 8,046,399,253.87 | 7,973,815,371.72 | 8,531,173,482.01 |
| 资产总计 | 19,370,646,001.43 | 19,459,731,168.89 | 19,226,846,916.32 | 19,330,801,003.68 |
| 流动负债: | | | | |
| 流动负债合计 | 3,190,237,710.37 | 3,176,761,172.13 | 3,134,024,673.74 | 3,361,062,623 |
| 非流动负债: | | | | |
| 非流动负债合计 | 250,851,561.78 | 246,106,858.24 | 248,098,457.85 | 271,156,862.35 |
| 负债合计 | 3,441,089,272.15 | 3,422,868,030.37 | 3,382,123,131.59 | 3,632,219,485.35 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 13,786,142,861.42 | 13,917,240,628 | 13,778,841,921.79 | 13,638,317,886.42 |
| 股东权益合计 | 15,929,556,729.28 | 16,036,863,138.52 | 15,844,723,784.73 | 15,698,581,518.33 |
| 负债和股东权益合计 | 19,370,646,001.43 | 19,459,731,168.89 | 19,226,846,916.32 | 19,330,801,003.68 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 3,643,600,300.45 | 1,464,196,671.75 | 9,599,726,837.9 | 6,721,251,815.51 |
| 经营活动现金流出小计 | 3,595,322,373.8 | 1,827,510,611.32 | 7,901,637,784.57 | 5,579,622,080.4 |
| 经营活动产生的现金流量净额 | 48,277,926.65 | -363,313,939.57 | 1,698,089,053.33 | 1,141,629,735.11 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 3,510,832,108.72 | 1,989,181,756.51 | 4,635,010,366.04 | 3,409,427,498.6 |
| 投资活动现金流出小计 | 3,720,710,706.04 | 1,940,296,829.03 | 7,026,620,864.02 | 5,084,227,052.07 |
| 投资活动产生的现金流量净额 | -209,878,597.32 | 48,884,927.48 | -2,391,610,497.98 | -1,674,799,553.47 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | 40,000,000 | - |
| 筹资活动现金流出小计 | 284,713,961.72 | 5,273,823.32 | 1,682,443,137.06 | 1,640,972,146.1 |
| 筹资活动产生的现金流量净额 | -284,713,961.72 | -5,273,823.32 | -1,642,443,137.06 | -1,640,972,146.1 |
| 汇率变动对现金及现金等价物的影响 | -13,914,140.26 | -6,150,170.86 | 15,344,679.24 | 18,636,588.38 |
| 现金及现金等价物净增加额 | -460,228,772.65 | -325,853,006.27 | -2,320,619,902.47 | -2,155,505,376.08 |
| 期末现金及现金等价物余额 | 3,364,165,409.39 | 3,498,541,175.77 | 3,824,394,182.04 | 3,989,508,708.43 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -460,228,772.65 | - | -2,320,619,902.47 | - |